Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial

被引:8
|
作者
Schepens, Tom [1 ]
Janssens, Koen [2 ]
Maes, Sabine [3 ]
Wildemeersch, Davina [3 ]
Vellinga, Jurryt [4 ]
Jorens, Philippe G. [1 ]
Saldien, Vera [3 ]
机构
[1] Antwerp Univ Hosp, Dept Crit Care Med, Edegem, Belgium
[2] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium
[3] Antwerp Univ Hosp, Dept Anesthesia, Edegem, Belgium
[4] MedMen, Groningen, Netherlands
关键词
Neuromuscular blockade; Neuromuscular blocking agents; Sugammadex; Neostigmine; Respiratory outcome; ELECTROMYOGRAPHIC ACTIVITY; BLOCKING-AGENTS; REVERSAL;
D O I
10.1186/s12871-019-0863-y
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background The use of neostigmine after neuromuscular blockade (NMB) has been associated with postoperative respiratory complications. In previous studies, we found lower diaphragmatic activity after neostigmine reversal of NMB, compared to sugammadex. It is still unclear whether the adequate use of neostigmine guarantees normal respiratory muscle function after NMB. In this study, we wanted to assess the effect of commonly used degrees of NMB and their possible reversal strategies on respiratory muscle activity after the return of normal neuromuscular transmission. Methods This is a randomized, controlled, parallel-group, single-centre, double-blind study in patients scheduled for intracranial surgery at a tertiary academic hospital in Belgium. All participants received target controlled propofol/remifentanil anesthesia and were randomized into one of five groups, receiving either a shallow NMB with no reversal (shallow/saline), a shallow NMB with sugammadex reversal (shallow/sugammadex), a moderate NMB with neostigmine reversal (moderate/neostigmine), a moderate NMB with sugammadex reversal (moderate/sugammadex), or a deep NMB with sugammadex reversal (deep/sugammadex). Primary and secondary outcome parameters were diaphragm and intercostal electromyographic (EMG) activity at the moment of resumed spontaneous breathing activity, defined as a maximal interval of 10 min after the first spontaneous breath. Results For the five groups, a total of 55 patients could be included in the final analysis. Median time of spontaneous breathing analyzed was 5 min (IQR 3-9.5 min). Both the moderate/sugammadex and the moderate/neostigmine groups had lower levels of diaphragm EMG compared to the shallow/sugammadex group. The moderate/neostigmine group had lower levels of intercostal EMG activity compared to the shallow/saline group. Conclusions In this study, the depth of neuromuscular blockade and type of reversal strategy impacts respiratory muscle activity at the moment of resumed spontaneous breathing and recovery of neuromuscular blockade. Both groups that received moderate NMB had lower levels of diaphragm EMG, compared to the shallow NMB group with sugammadex reversal. Compared to the shallow NMB group with no reversal, the moderate NMB with neostigmine reversal group had lower intercostal EMG activity.
引用
收藏
页数:7
相关论文
共 43 条
  • [41] Comparison of Operating Conditions, Postoperative Pain and Recovery, and Overall Satisfaction of Surgeons with Deep vs. No Neuromuscular Blockade for Spinal Surgery under General Anesthesia: A Prospective Randomized Controlled Trial
    Oh, Seok Kyeong
    Kwon, Woo-Keun
    Park, Sangwoo
    Ji, Sul Gi
    Kim, Joo Han
    Park, Youn-Kwan
    Lee, Shin Young
    Lim, Byung Gun
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (04):
  • [42] Maintaining Optimal Surgical Conditions With Low Insufflation Pressures is Possible With Deep Neuromuscular Blockade During Laparoscopic Colorectal Surgery A Prospective, Randomized, Double-Blind, Parallel-Group Clinical Trial
    Kim, Myoung Hwa
    Lee, Ki Young
    Lee, Kang-Young
    Min, Byung-Soh
    Yoo, Young Chul
    MEDICINE, 2016, 95 (09)
  • [43] Diaphragm ultrasound to evaluate the antagonistic effect of sugammadex on rocuronium after liver surgery in patients with different liver Child-Pugh grades: study protocol for a prospective, double-blind, non-randomised controlled trial
    Sun, Shujun
    Sun, Yan
    Chen, Rui
    Yao, Chunlin
    Xia, Haifa
    Chen, Xiangdong
    Lin, Yun
    Yao, Shanglong
    BMJ OPEN, 2022, 12 (02):